Gemcitabine plus Oxaliplatin (GEMOXI): a feasible treatment in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Corradini, G. M. [1 ]
Candido, P. [1 ]
Della Torre, S. [1 ]
Zannier, F. [1 ]
Cozzi, C. [1 ]
Belloni, P. [1 ]
Toniolo, D. [1 ]
Bollina, R. [1 ]
Tagliaferro, G. [1 ]
机构：
[1] Azienda Osped G Salvini, Div Med Oncol, Rho, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷
关键词：
D O I：
10.1016/S1040-8428(09)70146-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [1] Gemcitabine plus capecitabine in elderly patients with advanced pancreatic cancer
    Vasiliki, Michalaki
    Andreas, Poydorou
    Antonios, Vezakis
    Georgios, Frangulidis
    Theodosios, Theodosopoulos
    Christos, Papadimitriou
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Gemoxi a gentle treatment in patients with advanced pancreatic cancer
    Cozzi, C.
    Foa, P.
    Belloni, P.
    Toniolo, D.
    Clerici, M.
    Bollina, R.
    ANNALS OF ONCOLOGY, 2005, 16 : 53 - 53
  • [3] Combination therapy with Oxaliplatin plus Gemcitabine in advanced pancreatic cancer
    Klapdor, R
    Martini-Svendsen, J
    Seutter, R
    Fenner, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S146 - S146
  • [4] Gemcitabine plus oxaliplatin in advanced or metastatic pretreated pancreatic cancer
    Anghel, Rodica M.
    Popescu, Irinel
    Ionescu, Mihnea
    Stanculeanu, Dana
    Minea, Laurentia
    Bacinschi, Xenia
    Cringeanu, Alexandrina
    ANNALS OF ONCOLOGY, 2006, 17 : 325 - 325
  • [5] A Randomized Multicenter Trial of Capecitabine plus Oxaliplatin (CapOx) versus Capecitabine plus Gemcitabine (CapGem) versus Gemcitabine plus Oxaliplatin (GemOx) in the treatment of patients with advanced pancreatic cancer
    Golf, Alexander
    Hoehler, Thomas
    Seipelt, Gernot
    Mahlberg, Rolf
    Wein, Axel
    Hichhaus, Andreas
    Schmid, Birgit
    Boeck, Hans-Peter
    Hinke, Axel
    Boeck, Stefan
    Heinemann, Volker
    ANNALS OF ONCOLOGY, 2004, 15 : 243 - 243
  • [6] Gemcitabine in elderly patients with advanced pancreatic cancer
    Olivia Hentic
    Vinciane Rebours
    Philippe Lévy
    Philippe Ruszniewski
    Pascal Hammel
    Magaly Zappa
    Chantal Dreyer
    Eric Raymond
    World Journal of Gastroenterology, 2011, 17 (30) : 3497 - 3502
  • [7] Gemcitabine in elderly patients with advanced pancreatic cancer
    Hentic, Olivia
    Dreyer, Chantal
    Rebours, Vinciane
    Zappa, Magaly
    Levy, Philippe
    Raymond, Eric
    Ruszniewski, Philippe
    Hammel, Pascal
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (30) : 3497 - 3502
  • [8] Randomized comparison of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx) in advanced pancreatic cancer
    Heinemann, V.
    Hoehler, T.
    Seipelt, G.
    Wein, A.
    Golf, A.
    Mahlberg, R.
    Schmid, B.
    Boeck, S.
    Neugebauer, S.
    Hochhaus, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 209 - 209
  • [9] Gemcitabine plus oxaliplatin combination in patients with advanced biliary tract cancer
    Vattemi, E.
    Lusso, M.
    Pedersini, R.
    Baier, S.
    Cretella, E.
    Petric, M.
    Stocker, J.
    Graiff, C.
    ANNALS OF ONCOLOGY, 2007, 18 : VII111 - VII111
  • [10] Randomised trial of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx)in advanced pancreatic cancer.
    Heinemann, V
    Golf, A
    Seipelt, G
    Bauer, J
    Höhler, T
    Clemens, M
    Löhr, JM
    Stauch, M
    Lordick, F
    Hinke, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 340S - 340S
12345